Gantenbein AR, Agosti R, Gobbi C, Flugel D, et al. Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study. Cephalalgia 2021 May 17:3331024211014616. doi: 10.1177/03331024211014616.
PMID: 34000847